Asymmetric dimethylarginine (ADMA) and treatment response relationship in male patients with first-episode schizophrenia: A controlled study

Psychiatry Research

Volumn 220, Issue 1-2, 2014, Pages 76-80

  Zincir, Serkan ^a   Zincir, Selma Bozkurt ^b   Doruk, Ali ^c   Erdem, Murat ^c   Celik, Cemil ^c   Ak, Mehmet ^d   Garip, BeyazIt ^c   Yükselir, Cihad ^c   Karaahmetoğlu, Bülent ^c  

^a Department of Psychiatry   (Turkey)

^b Erenkoy Mental Research and Training Hospital   (Turkey)

^c GULHANE SCHOOL OF MEDICINE   (Turkey)

^d Medicana Hospital   (Turkey)

Author keywords

ADMA; Nitric oxide; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; HALOPERIDOL; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; OLANZAPINE; QUETIAPINE; RISPERIDONE; ARGININE; N,N-DIMETHYLARGININE; NEUROLEPTIC AGENT;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; HUMAN; MALE; OUTCOME ASSESSMENT; SCHIZOPHRENIA; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; BLOOD; DRUG EFFECTS; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; ARGININE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; SCHIZOPHRENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908239473     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.07.013     Document Type: Article

References (24)

1. Andreasen N.C. Methods for assessing positive and negative symptoms. Modern Problems of Pharmacopsychiatry 1990, 24:73-788.
2. Aykut D., Tiryaki A., Özkorumak E, Karahan C. Nitric oxide and asymmetrical dimethylarginine levels in acute mania. Bulletin of Clinical Psychopharmacology 2012, 22(1):10-16.
3. Beltowski J., Kedra A. Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy. Pharmacological Reports 2006, 58(2):159-178.
4. Boger R.H., Bode-Boger S.M., Tsao P.S., Lin P.S., Chan J.R., Cooke J.P. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. Journal of the American College of Cardiology 2000, 36(7):2287-2295.
5. Celik C., Cayci T., Ozdemir B., Akgul E.O., Zincir S., Balikci A., Uzun O., Yaman H. Plasma asymmetric dimethylarginine (ADMA) concentrations in patients with first and multiple episode schizophrenia. Psychiatry Research 2011, 190(2-3):177-180.
6. Chen BM., Xia LW., Zhao RQ. Determination of N(G),N(G)-dimethylarginine in human plasma by high-performance liquid chromatography. Journal of chromatography B: Biomedical Sciences and Applications 1997, 692(2):467-471.
7. Das I., Khan N.S., Puri B.K., Sooranna S.R., deBelleroche J., Hirsch S.R. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochemical and Biophysical Research Communications 1995, 212(2):375-380.
8. Das I., Khan N.S., Puri B.K., Hirsch S.R. Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neuroscience Letters 1996, 215(3):209-211.
9. Das I., Ramchand C.N., Gliddon A., Hirsch S.R. Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia. Neuropsychobiology 1998, 37(2):65-67.
10. Erbil M., Kurt Y.G., Yaman H., Akgül E.Ö., ÇaycI T. Asimetrik dimetilarginin metabolizmasI ve klinik önemi. Turkish Journal of Biochemistry 2012, 37(1):99-105.
11. Erkoc S., Arkonac O., AtaklI C., Ozmen E. Negatif semptomlarI değerlendirme ölçeğinin güvenilirliği ve geçerliliği. Düşünen Adam 1991, 4:16-19.
12. Erkoc S., Arkonac O., AtaklI C., Ozmen E. Pozitif semptomlarI değerlendirme ölçeğinin güvenilirliği ve geçerliliği. Düşünen Adam 1991, 4:20-24.
13. Gattaz W.F., Cramer H., Beckmann H. Low CSF concentrations of cyclic GMP in schizophrenia. The British Journal of Psychiatry 1983, 142:288-291.
14. Jonasson T.F., Hedner T., Hultberg B., Ohlin H. Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease. European Journal of Clinical Investigation 2003, 33(7):543-599.
15. Lukoff, D., Nuechhtriein, K.H., Vertuna, J., 1993. Brief Psychiatric Rating Scale (BPRS) Version 3.0, Expended Version. UCLA Deoartment of Psychiatry and Biobehaviriol Sciences, West Los Angeles Medical Center, Los Angeles.
16. Ramirez J., Garnica R., Boll M.C., Montes S., Rios C. Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study. Schizophrenia Research 2004, 68(2-3):357-361.
17. Siroka R., Trefil L., et al. Asymmetric dimethylarginine-comparison of HPLC and ELISA methods. Journal of Chromatography 2007, 850:586-587.
18. Sniezawska A., Dorszewska J., Rozycka A., Przedpelska-Ober E., Lianeri M., Pawel P., et al. MTHFR, MTR, and MTHFD1 gene polymorphisms compared to homocysteine and asymmetric dimethylarginine concentrations and their metabolites in epileptic patients treated with antiepileptic drugs. Seizure 2011, 20(7):533-540.
19. Soykan C. Institutional differences, and case typicality as related to diagnosis system severity, prognosis and treatment 1989, (Unpublished), Middle East Technical University, Ankara, (Master's thesis).
20. Srivastava N., Barthwal M.K., Dalal P.K., Agarwal A.K., Nag D., Srimal R.C., Seth P.K., Dikshit M. Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients. Psychopharmacology 2001, 158(2):140-145.
21. Stuhlinger M.C., Abbasi F., Chu J.W., Lamendola C., McLaughlin T.L., Cooke J.P., Reaven G.M., Tsao P.S. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. The Journal of the American Medical Association 2002, 287(11):1420-1426.
22. Suzuki E., Nakaki T., Nakamura M., Miyaoka H. Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia. Journal of Psychiatry and Neuroscience 2003, 28(4):288-292.
23. Vallance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992, 339(8793):572-575.
24. Wanby P., Brattstrom L., Brudin L., Hultberg B., Teerlink T. Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading. Scandinavian Journal of Clinical and Laboratory Investigation 2003, 63(5):347-353.